The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort.

Edgar Carnero ContenttiClaudia PestchankerEthel Leslie CiampiSheila Castro SuarezCésar Caparó-ZamalloaVanesa Daccach MarquesKatharina MessiasJosé Ignacio GortariVerónica TkachukBerenice Anabel SilvaCarolina MainellaSaúl ReyesJaime ToroJuan RodriguezEdgar Correa-DiazJuan I RojasFriedemann Paul

Published in: European journal of neurology (2024)

These findings support the diagnostic utility of the 2023 MOGAD criteria in an LATAM cohort in real-world practice, despite limited access to MOG-IgG titration.

Keyphrases

primary care
healthcare
white matter
quality improvement
multiple sclerosis